Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudyZhe Zhang(Sun Yat-sen University), Yanhong Wang(Fudan University)BMC MedicineAugust 24, 200910.1186/1741-7015-7-41Cited by 147SaveCiteExport RISWatch citationsRelated PapersSchedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma|BMC Cancer|2013|21An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells|Oncotarget|2017|6Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation|FEBS Open Bio|2019|6